Literature DB >> 19809319

Multiple sclerosis. Part I: neuro-ophthalmic manifestations.

John H Pula1, Anthony T Reder.   

Abstract

PURPOSE OF REVIEW: This update includes topics relating to multiple sclerosis (MS) for the ophthalmologist. RECENT
FINDINGS: Interest in the ophthalmology of MS is highlighted by the substantial amount of original research presented at recent medical conferences. At the 2008 World Congress on Treatment and Research in Multiple Sclerosis, 33 of 898 abstract presentations related to ophthalmology. The most represented topics were optical coherence tomography (OCT) and radiology of the visual system (19/33 posters). The 2009 North American neuro-ophthalmologic society (NANOS) conference featured MS-related topics in 6 of 24 platform presentations. This article reviews recent advancements in the neuro-ophthalmology of MS.
SUMMARY: Multiple sclerosis results in various ophthalmic abnormalities. Optic neuritis is the most widely studied visual disturbance in MS, but other unusual visual manifestations such as Charles Bonnet syndrome or the Pulfrich phenomenon also occur. OCT is used to measure thickness of the retinal nerve fiber layer. Because thinning of this layer in MS represents axonal loss, OCT is being used to evaluate neuroprotective treatments. The efferent visual system, in particular the medial longitudinal fasciculus pathway, may be a way to measure body temperature-induced changes in MS.

Entities:  

Mesh:

Year:  2009        PMID: 19809319     DOI: 10.1097/ICU.0b013e328331913b

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods.

Authors:  Mabel Enriquez-Algeciras; Di Ding; Tsung-Han Chou; Jianhua Wang; Kyle R Padgett; Vittorio Porciatti; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-14       Impact factor: 4.799

2.  Corticosteroid-associated atypical central serous chorioretinopathy in a patient with multiple sclerosis.

Authors:  Mahmut Kaya; Derya Kaya; Egemen Idiman
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

3.  Decreased Ocular Pulse Amplitude and Retinal Nerve Fibre Layer in Multiple Sclerosis.

Authors:  Ebru N Cetin; Cagdas Erdogan; Semra Acer; Gülden Sarac; Cem Yıldırım; Levent S Bir
Journal:  Neuroophthalmology       Date:  2013-05-31

4.  Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update.

Authors:  Susana Noval; Inés Contreras; Silvia Muñoz; Celia Oreja-Guevara; Beatriz Manzano; Gema Rebolleda
Journal:  Mult Scler Int       Date:  2011-06-02

Review 5.  Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.

Authors:  Juliana Muñoz-Ortiz; Juliana Reyes-Guanes; Estefanía Zapata-Bravo; Laura Mora-Muñoz; Juan Antonio Reyes-Hurtado; Luis Octavio Tierradentro-García; William Rojas-Carabali; Marcela Gómez-Suarez; Alejandra de-la-Torre
Journal:  Syst Rev       Date:  2021-10-28

6.  Current options for the treatment of optic neuritis.

Authors:  John H Pula; Christopher J Macdonald
Journal:  Clin Ophthalmol       Date:  2012-07-31

7.  Clinical features of visual disturbances secondary to isolated sphenoid sinus inflammatory diseases.

Authors:  Lanlan Chen; Libin Jiang; Bentao Yang; Prem S Subramanian
Journal:  BMC Ophthalmol       Date:  2017-12-06       Impact factor: 2.209

8.  Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis.

Authors:  Maria T Sekyi; Kelli Lauderdale; Kelley C Atkinson; Batis Golestany; Hawra Karim; Micah Feri; Joselyn S Soto; Cobi Diaz; Sung Hoon Kim; Marianne Cilluffo; Steven Nusinowitz; John A Katzenellenbogen; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2021-01-29       Impact factor: 6.508

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.